DDR on DTC: NuvaRing

Share this article:
DDR on DTC: NuvaRing
DDR on DTC: NuvaRing

Organon/Merck has launched a DTC campaign for its NuvaRing female contraceptive, and it does a good job announcing the brand despite several challenges. First, this is a device that also delivers contraceptive hormonal medication... which leads to the second challenge—voluminous Fair Balance. Finally, the category itself (Birth Control) can be difficult in terms of media placements.

In spite of the challenges, NuvaRing comes across as an innovative product for young, active—and definitely single—women. The campaign uses the expression “OH” to represent the excited response women have to learning about the brand and to reinforce the shape of the product. The brand benefit that elicits the excited response is ease-of-use because “you don't have to take it every day” (like pesky, old-fashioned pills). In both the print and TV ads, we see a woman holding the device. This visual is important to convey the product's sleekness and convenience. It also contributes a new/modern tonality to the brand itself.

Unfortunately, the Fair Balance overwhelms the single-page print ad to the degree that we really have to work to find out what the brand is/does. The benefit copy seems inconsequential in print. On TV, we can look at those beautiful young women having fun while the FB drones on—but we can see that they are interested in NuvaRing because they keep saying “OH.” In this case, let's hope that's enough to do the trick in terms of recall and memorability for this new brand.

Deborah Dick-Rath is SVP, healthcare, at Symphony Advanced Me­dia, ddickrath@symphonyam.com
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?